TNFRSF10B and systemic sclerosis: Accordingly, fibrotic fibroblasts from SSc patients were sensitive to TLY012 and humanized anti-DR5 agonistic antibody (1 μg/mL), conatumumab, compared to that of normal fibroblasts (Supplementary Fig. 2c).